Azithromycin: Difference between revisions
Jump to navigation
Jump to search
Pat Palmer (talk | contribs) (rduplicate ref name) |
mNo edit summary |
||
| Line 9: | Line 9: | ||
==References== | ==References== | ||
<references/> | <references/>[[Category:Suggestion Bot Tag]] | ||
Latest revision as of 06:01, 15 July 2024
In medicine, azithromycin is a "semi-synthetic macrolide antibiotic structurally related to erythromycin. It has been used in the treatment of Mycobacterium avium intracellular infections, toxoplasmosis, and cryptosporidiosis."[1]
Development
Azithromycin was patented in 1982.[2] Zithromax was approved by the Food and Drug Administration for Pfizer in 1991.[3] Non-authorized generic drugs manufactured by Teva, Sandoz, and Abraxis were approved in the United States of America starting in 2005.[4]
Drug toxicity
Drug toxicity includes cardiovascular death.[5]
References
- ↑ Anonymous (2024), Azithromycin (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ patent:4328334 - Google Patents. Retrieved on 2009-02-01.
- ↑ Drugs@FDA. Food and Drug Administration. Retrieved on 2009-02-01.
- ↑ Drugs@FDA. Food and Drug Administration. Retrieved on 2009-02-01.
- ↑ Ray et al. (2012) Azithromycin and the Risk of Cardiovascular Death